Taro Pharmaceutical
TARO
$42.23
Share price
-0.07%
Change (1 day)
65.22%
Change (1 year)
Categories
EPS for Taro Pharmaceutical (TARO)
EPS in 2023 (TTM): $0.61
According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is $0.61. In 2021 the company made an earnings per share (EPS) of $0.04000 an increase over its 2020 EPS that were of -$7.91.
EPS history for Taro Pharmaceutical from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.61 | |
| 2021 | $0.04000 | -100.51% |
| 2020 | -$7.91 | -222.45% |
| 2019 | $6.46 | -18.02% |
| 2018 | $7.88 | 53.01% |
| 2017 | $5.15 | -55.95% |
| 2016 | $11.69 | -13.41% |
| 2015 | $13.50 | 36.92% |
| 2014 | $9.86 | 37.71% |
| 2013 | $7.16 | 21.15% |
| 2012 | $5.91 | 44.15% |
| 2011 | $4.10 | 175.17% |
| 2010 | $1.49 | -48.8% |
| 2009 | $2.91 | |
| 2005 | $0.03000 | -91.89% |
| 2004 | $0.37 | -82.55% |
| 2003 | $2.12 | 35.9% |
| 2002 | $1.56 | 39.29% |
| 2001 | $1.12 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | 2,209.07% | 🇺🇸 USA |
 Novartis NVS | $3.74 | 513.11% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | 204.92% | 🇺🇸 USA |
 Merck MRK | $1.82 | 198.64% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | 473.89% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$2.00 | -427.87% | 🇮🇱 Israel |